Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
Author(s):
Humby, F.; Lewis, M.; Ramamoorthi, N.; Hackney, J.A.; Barnes, M.R.; Bombardieri, M.; Setiadi, A.F.; Kelly, S.; Bene, F.; DiCicco, M.; Riahi, S.; Rocher, V.; Ng, N.; Lazarou, I.; Hands, R.; Heijde, D. van der; Landewe, R.B.M.; Helm-van Mil, A. van der; Cauli, A.; McInnes, I.; Buckley, C.D.; Choy, E.H.; Taylor, P.C.; Townsend, M.J.; Pitzalis, C.
Published
2019
Publication type
Article / Letter to editor
Date issued
2019-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2019), Vol. 78, no. 6, p. 761-772
